Antimalarial Activity of Ethyl Acetate and n-Hexane Fractions of Ashitaba Leaves (Angelica keiskei K.)

Author:

K. Wardani Alvi1,Safwan Safwan1,Hapsari Ni P.1,Hendriyani Irmatika2,Ridwansyah Muhammad T.2,Wahid Abdul R.1

Affiliation:

1. Department of Phytochemical and Pharmacognosy, Faculty of Health Sciences, University of Muhammadiyah Mataram 83127, West Nusa Tenggara, Indonesia.

2. Department of Pharmaceutical Chemistry, Faculty of Health Sciences, University of Muhammadiyah Mataram 83127, West Nusa Tenggara, Indonesia.

Abstract

Malaria is a parasitic disease that is still a serious health problem globally, especially in tropical and sub-tropical countries. Data from the Ministry of Health of the Republic of Indonesia, 261,671 malaria cases were in Indonesia until 2017, 100 of which died. One of the main factors causing the increase in malaria infection is resistance to antimalarial drugs. Resistance to antimalarial drugs can be overcome, one of which is by utilizing plants that have the potential as antimalarials. Several compounds derived from plants have been shown to have antiplasmodium activity, and have the potential to be developed as antimalarials, one of which is chalcone. This study aimed to determine the antimalarial activity of the ethyl acetate and n-hexane fractions of Ashibata leaves as a new alternative for malaria treatment. This study used a true experimental type of research with a posttest-only control group design approach microscopically against the parasite Plasmodium falciparum strain 3D7. The ethyl acetate and n-hexane fraction of ashitaba leaves were tested at concentrations of 0.01 µg/ml, 0.1 µg/ml, 1 µg/ml, 10 µg/ml, and 100 µg/ml. The results showed that both fractions had very active inhibitory activity on Plasmodium falciparum strain 3D7, with the IC50 values of the ethyl acetate fraction being 4.77 µg/ml and 4.38 µg/ml, respectively.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference24 articles.

1. Ministry of Health of the Republic of Indonesia. (2020). TatalaksanaKasus Malaria. 1–44. http://www.malaria.id/p/buku-malaria.html

2. Roll Back Malaria Partnership (WHO). (2008). The Global Global Malaria Malaria Action Plan For a malaria free world. Director, 274.

3. WHO. (2020). World Malaria Report: 20 years of global progress and challenges. In World Health: Vol. WHO/HTM/GM (December). https://www.who.int/publications/i/item/9789240015791

4. Ministry of Health of the Republic of Indonesia. 2022. Malaria: The Highest Cause of Death in The World. https://www.malaria.id/en/profile(accessed on April 2022)

5. NTB Satu Data. 2020. JumlahKasus Malaria Positif di Provinsi NTB. Dinas Kesehatan Provinsi NTB. Mataram. https://data.ntbprov.go.id/dataset/jumlah-kasus-malaria-positif-di-provinsi-ntb (accessed on April 2022)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3